EHC Encompass Health Corp
Services-Hospitals · NYSE · SEC CIK 785161 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.4%
TTM net income YoY19.1%
TTM EPS YoY21.0%
Revenue 3-yr CAGR10.5%
Net income 3-yr CAGR22.1%
Margins
Gross margin—
Operating margin—
Net margin10.2%
FCF margin7.2%
EBITDA margin—
Returns
ROE25.5%
ROA8.9%
ROIC (approx.)—
Asset turnover0.88x
Leverage & solvency
Liabilities / assets52.9%
Debt / equity0.97x
Current ratio1.09x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.02x
Accruals ratio-9.1%
Payout ratio11.9%
Capex / revenue13.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.61B | $1.60B | $1.59B | $1.54B | $1.48B | $1.46B | $1.46B | $1.41B |
| SG&A expense | $59.90M | $62.60M | $58.20M | $68.40M | $56.10M | $59.40M | $52.30M | $54.50M |
| Interest expense | $32.20M | $32.80M | $31.80M | $30.20M | $30.80M | $30.40M | $31.80M | $33.00M |
| Pretax income | $257.80M | $261.60M | $288.70M | $257.70M | $219.90M | $236.80M | $238.60M | $201.40M |
| Income tax | $53.40M | $53.60M | $56.40M | $55.40M | $44.90M | $51.00M | $41.60M | $37.60M |
| Net income | $149.90M | $153.90M | $194.50M | $146.10M | $126.50M | $142.10M | $151.50M | $120.90M |
| EPS (basic) | 1.52 | 1.55 | 1.96 | — | 1.26 | 1.41 | 1.50 | — |
| EPS (diluted) | 1.50 | 1.54 | 1.93 | — | 1.24 | 1.39 | 1.48 | — |
| Dividends declared per share | 0.21 | 0.19 | 0.19 | 0.19 | 0.19 | 0.17 | 0.17 | 0.17 |
| Weighted avg. shares (diluted) | 99.70M | 100.00M | 100.60M | — | 102.30M | 102.30M | 102.10M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $76.20M | $107.70M | $110.50M | $72.20M | $48.70M | $99.10M | $95.80M | $85.40M |
| Receivables | $712.00M | $687.30M | $676.00M | $619.20M | $610.80M | $612.50M | $623.40M | $593.00M |
| Current assets | $1.01B | $1.04B | $1.03B | $905.90M | $869.80M | $918.10M | $910.90M | $886.90M |
| PP&E, net | $4.48B | $4.34B | $4.22B | $4.10B | $3.93B | $3.82B | $3.72B | $3.64B |
| Goodwill | $1.32B | $1.32B | $1.32B | $1.32B | $1.30B | $1.30B | $1.28B | $1.28B |
| Intangibles | $301.50M | $306.80M | $300.30M | $308.30M | $291.90M | $295.90M | $294.50M | $297.80M |
| Total assets | $7.57B | $7.46B | $7.31B | $7.09B | $6.87B | $6.79B | $6.64B | $6.53B |
| Current liabilities | $927.40M | $873.40M | $876.80M | $836.40M | $762.00M | $865.10M | $856.00M | $841.00M |
| Short-term debt | $47.80M | $35.90M | $42.90M | $43.60M | $39.00M | $139.20M | $138.70M | $138.60M |
| Long-term debt | $2.55B | $2.60B | $2.53B | $2.45B | $2.39B | $2.32B | $2.33B | $2.36B |
| Total debt | $2.60B | $2.63B | $2.57B | $2.49B | $2.43B | $2.46B | $2.47B | $2.50B |
| Total liabilities | $4.01B | $4.00B | $3.95B | $3.81B | $3.68B | $3.70B | $3.70B | $3.69B |
| Shareholders' equity | $2.68B | $2.60B | $2.52B | $2.44B | $2.37B | $2.28B | $2.16B | $2.07B |
| Net debt | $2.52B | $2.53B | $2.46B | $2.42B | $2.38B | $2.36B | $2.38B | $2.41B |
| Cash flow statement | ||||||||
| Operating cash flow | $362.00M | $282.60M | $313.10M | $346.00M | $270.80M | $270.20M | $288.60M | $278.80M |
| Capital expenditure | $234.50M | $220.30M | $162.40M | $229.30M | $187.10M | $156.90M | $163.10M | $198.70M |
| Free cash flow | $127.50M | $62.30M | $150.70M | $116.70M | $83.70M | $113.30M | $125.50M | $80.10M |
| Investing cash flow | -$241.60M | -$235.60M | -$150.10M | -$239.40M | -$201.30M | -$165.40M | -$158.50M | -$203.70M |
| Financing cash flow | -$153.70M | -$76.90M | -$102.50M | -$97.40M | -$113.20M | -$90.20M | -$130.40M | -$150.90M |
| Depreciation & amortization | $95.70M | $90.40M | $87.30M | $86.40M | $82.40M | $79.90M | $79.20M | $78.00M |
| Stock-based compensation | $15.00M | $13.80M | $11.50M | $18.40M | $14.30M | $14.30M | $9.50M | $12.50M |
| Dividends paid | $18.70M | $18.90M | $20.30M | $19.00M | $17.00M | $17.10M | $18.00M | $17.00M |
| Share buybacks | $57.90M | $74.20M | $71.60M | $76.30M | $24.90M | $24.70M | $32.10M | $7.50M |
Free plan shows the latest 8 periods; Pro shows all 70 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.